5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hyper engorged cancer associated macrophage-like cells in circulation predict for multi-organ metastatic disease in solid tumors
    Meeting Abstract

    Gironda, D. J.; Bergan, R. C.; Lin, S. H.; Alpaugh, R. K.; Cristofanilli, M.; Chumsri, S.; Lapidus, R. G.; Williams, W.; Lacher, M.; Danila, D. C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • First-in-human, phase I study of PF-06753512, a vaccine-based immunotherapy regimen (PrCa VBIR), in biochemical relapse (BCR) and metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Higano, C. S.; Nordquist, L. T.; Appleman, L. J.; Zhang, T.; Zhu, X.; Babiker, H. M.; Vogelzang, N. J.; Prasad, S.; Schweizer, M. T.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Cabozantinib (C) exposure-response (ER) analysis for the phase 3 CheckMate 9ER (CM 9ER) trial of nivolumab plus cabozantinib (N+C) versus sunitinib (S) in first-line advanced renal cell carcinoma (1L aRCC)
    Meeting Abstract

    Shah, A. Y.; Motzer, R. J.; Apolo, A. B.; Powles, T.; Escudier, B.; Zhang, J.; Scheffold, C.; Karumanchi, S.; Nguyen, L. T.; Choueiri, T. K.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Efficacy of avelumab + axitinib (A + Ax) versus sunitinib (S) by IMDC risk group in advanced renal cell carcinoma (aRCC): Extended follow-up results from JAVELIN Renal 101
    Meeting Abstract

    Haanen, J. B. A. G.; Larkin, J.; Choueiri, T. K.; Albiges, L.; Rini, B. I.; Atkins, M. B.; Schmidinger, M.; Penkov, K.; Thomaidou, D.; Wang, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • First-in-human study of TAS3681, an oral androgen receptor (AR) antagonist with AR and AR splice variant (AR-SV) downregulation activity, in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) refractory to abiraterone (ABI) and/or enzalutamide (ENZ) and chemotherapy (CT)
    Meeting Abstract

    De Bono, J. S.; Cook, N.; Yu, E. Y.; Lara, P. N.; Wang, J. S.; Yamasaki, Y.; Yamamiya, I.; Gao, P.; Calleja, E. M.; Rathkopf, D. E.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Late immune-related adverse events with immune checkpoint inhibitors
    Meeting Abstract

    Ip, A.; Wang, S.; Cheruku, D.; Krishnamurthy, K.; Weber, M.; Sinclaire, B.; Paleoudis, E. G.; Alaoui, A.; Lev-Ari, S.; Serzan, M. T.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Pembrolizumab (pembro) in combination with gemcitabine (Gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial cancer of the bladder (MIBC): A multicenter phase 2 trial
    Meeting Abstract

    Balar, A. V.; Milowsky, M. I.; O'Donnell, P. H.; Alva, A. S.; Kollmeier, M.; Rose, T. L.; Pitroda, S.; Kaffenberger, S. D.; Rosenberg, J. E.; Francese, K.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Lenvatinib (LEN) + pembrolizumab (PEMBRO) treatment in patients (pts) with metastatic clear cell renal cell carcinoma (RCC): Final results of a phase 1b/2 trial
    Meeting Abstract

    Lee, C. H.; Shah, A. Y.; Hsieh, J. J.; Rao, A.; Pinto, A.; Bilen, M. A.; Cohn, A. L.; DiSimone, C.; Shaffer, D. R.; Sarrió, R. G.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Real-world outcomes of treatment with immune checkpoint inhibitors in unique patient cohorts: Elderly, non-caucasian race, poor performance status, obese, chronic viral infections, and autoimmune diseases
    Meeting Abstract

    Shah, N. J.; Wang, S.; Williams, A.; Weber, M.; Sinclaire, B.; Paleoudis, E. G.; Alaoui, A.; Lev-Ari, S.; Adams, S.; Kaufman, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Quality-adjusted time without symptoms of disease progression or toxicity (Q-TWiST) of nivolumab plus cabozantinib (N+C) versus sunitinib (SUN) in treatment-naïve, advanced/metastatic renal cell carcinoma (aRCC): A post-hoc analysis of CheckMate 9ER (CM 9ER) data
    Meeting Abstract

    Cella, D.; Motzer, R. J.; May, J.; Wallace, J.; Marteau, F.; Kwon, Y.; Rusibamayila, N.; Botteman, M.; Ejzykowicz, F.; Choueiri, T. K.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save